Eagle Telemedicine Adds Rheumatology Specialty to Suite of Flexible Telemedicine Services

Eagle Telemedicine, a pioneer in inpatient telemedicine, today announced the addition of a rheumatology specialty to its growing list of physician telemedicine services. The Eagle

TeleRheumatology service is a new specialty added to the company’s growing list of 15 specialized telemedicine services offered to hospitals and clinics nationwide to help them overcome the recruiting challenges during the current shortage of specialized physicians.

More than 54 million Americans live with rheumatic disease in the U.S., according to the Centers for Disease Control and Prevention (CDC), this is expected to grow to 67 million by 2030. Yet, with many practicing rheumatologists estimated to retire and a lack of new physicians entering the field, the number of rheumatologists is expected to decrease 24% to just 4,497 rheumatologists by 2030, This has generated an increased need for rheumatologist access, particularly among regional hospitals in rural communities. The Eagle TeleRheumatology service is rising to meet this increased need.

“The supply of physicians coming out of residency and fellowship programs, particularly in the field of rheumatology, is not keeping up with the rate of retirement for outgoing physicians,” said Jason Povio, President and Chief Operating Officer, Eagle Telemedicine. “This has created one of the most difficult recruitment challenges health systems have faced to date. To help bridge the rheumatology staffing gap, Eagle Telemedicine has added TeleRheumatology as a key new specialty to our suite of physician specialties available to deliver virtualized care to hospitals everywhere.”

Eagle Telemedicine offers technology-enabled inpatient and specialty care to address the physician shortage challenge. With more than 15 physician specialties, Eagle delivers more than 75,000 patient encounters, annually, to healthcare systems and hospitals in more than 35 states. Offering access to telemedicine specialists, 24/7, Eagle Telemedicine reduces patient referrals, increases physician retention and enhances hospitals’ overall quality of care.

Eagle TeleRheumatology specialty services are one of a complete list of telemedicine specialties available to healthcare system customers. From TeleICU and TeleNeurology to TeleCardiology TeleOncology, TelePediatrics, TelePhychiatry and more, Eagle delivers the specialized care hospitals of all sizes require in the face of physician shortages, recruiting challenges or night coverage needs.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”